De Vriese Carine, Delporte Christine
Laboratory of Biological Chemistry and Nutrition, Université Libre de Bruxelles, Brussels, Belgium.
Curr Opin Clin Nutr Metab Care. 2007 Sep;10(5):615-9. doi: 10.1097/MCO.0b013e32829fb37c.
The purpose of this review is to provide updated information on the role of ghrelin in food intake and energy homeostasis, and on its mechanism of action. Moreover, the potential of ghrelin as a target for drugs to treat cachexia and obesity will be discussed.
Whereas the effects of ghrelin in the regulation of appetite, food intake and energy homeostasis have been fairly well documented, the pathways responsible for the effects of ghrelin are now increasingly being understood. As a consequence, clinical applications of ghrelin are now being developed.
Ghrelin is an endogenous orexigenic peptide recently discovered in the stomach. Ghrelin is involved in short-term regulation of food intake since its plasma levels increase before meals and decrease strongly postprandially. Ghrelin is also involved in long-term body-weight regulation by inducing adiposity. Ghrelin might be useful for cachexia and obesity treatment.
本综述旨在提供有关胃饥饿素在食物摄入和能量平衡中的作用及其作用机制的最新信息。此外,还将讨论胃饥饿素作为治疗恶病质和肥胖症药物靶点的潜力。
尽管胃饥饿素在调节食欲、食物摄入和能量平衡方面的作用已有相当充分的文献记载,但导致胃饥饿素产生这些作用的途径现在越来越为人所知。因此,胃饥饿素的临床应用正在开发中。
胃饥饿素是一种最近在胃中发现的内源性促食欲肽。胃饥饿素参与食物摄入的短期调节,因为其血浆水平在饭前升高,饭后大幅下降。胃饥饿素还通过诱导肥胖参与长期体重调节。胃饥饿素可能对恶病质和肥胖症的治疗有用。